Rani Therapeutics Expands Obesity Pipeline With PegBio
SAN JOSE, Calif. | July 9, 2026 Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company pioneering oral biologic drug...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SAN JOSE, Calif. | July 9, 2026 Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company pioneering oral biologic drug...
ROCKVILLE, Maryland, June 2, 2026 Rise Therapeutics announced the completion of full enrollment in the four-week dose expansion cohort...
February 25, 2026 – Bagsværd, Denmark & Boston, Massachusetts, USA Novo Nordisk and Vivtex Corporation have announced a strategic...
